Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data.

Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends

Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel.

TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of the Company’s recurring-revenue platform.

Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared.

Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation.

Owlet expands its global footprint, entering one of the world’s most promising digital health markets, with CDSCO-approved technology.

Owlet’s new release creates the ultimate baby monitoring system for video, sleep, and medical-grade health tracking.

The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa.

This new subscription service, exclusive to Owlet users, gives parents a deeper, personalized understanding of their baby’s development, health, and sleep trends.

Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.

Owlet Expands Global Footprint with Launch of Medically-Certified Dream Sock™ in the UK and Across Europe